no in-person visits are required, symptom and activity trackers and smart scales will be used, and a few people will provide blood for labs
Notably, only one registered clinical study exists to date, which evaluates an implant-based delivery system of Exenatide and is currently in Phase 1 with an Active, not recruiting status (NCT05670379), initiated on December 20, 2024, and expected to conclude by August 2025
Results The effect of dietary L-carnitine supplementation on the carnitine concentration, carnitine synthesis gene expression and triglyceride levels in tissues During the experiment, the fish were in good health and showed no growth differences compared with control fish (data not shown)
GLP-1 receptors are present in brain regions involved in addiction and reward processing, and their activation may reduce the reinforcing effects of alcohol
Int J Clin Pharmacol Res 1990;10:123-8
Glucose-dependent insulinotropic polypeptide